Actually a prostate cancer patient died during an intravenous procedure in a trial. Regardless, whether or not it had to do with Cotara is not known.
I'm sure it raised more than one eyebrow with the FDA and the retail investors were never told about the mishap in a PR from what i can recall.
Bad mistake on Managements part.....
I don't believe Cotara had anything to do with the Patients death. Management pulled a big boner when they didn't fess up and educate the public and wall street with the details.
Your insightis much appreciated, Steve. "The Cotara story" is sounding more and more promising. Any thoughts on my other inquiries...Orphan and Dr. Thorpe? Now that I've had a chance to dive into Peregrine's history I've concluded that this is/was one strange story. What has kept them alive all these years and with no debt to speak of? Thanks again.
Market Data 
Markets 
AI
